Keywords: biogen, completes, eu, filing, amevive, completed, simultaneous

Biogen completes US and EU filing for Amevive

Article | 08 August 2001

Biogen has completed a simultaneous registration filing, initiatedearlier this year (Marketletter June 25), with the US Food and Drug Administration and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genentech

Go to company listing

Related Drugs

Alefacept

Amevive

Efalizumab

Raptiva

Go to drug listing